Related Experiment Video
Updated: Jul 5, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Adiponectin C1q/Tumor Necrosis Factor-Related Protein 13 (CTRP13) Protects against Renal Inflammation and Fibrosis in
Yongxia Li1,2, Wenzhe Wang2, Changxuan Liu2
1Department of Rheumatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Abstract:
Renal inflammation and fibrosis are the important pathological phenomena associated with obstructive nephropathy. However, the underlying mechanism associated with this disease has yet to be fully elucidated. The present study, therefore, aimed to investigate the effects mediated by C1q/tumor necrosis factor-related protein 13 (CTRP13) on renal inflammation and fibrosis in addition to elucidating the underlying mechanism. To meet this aim, a mouse unilateral ureteral obstruction (UUO)-mediated renal dysfunction model was established. In addition, hematoxylin-eosin staining (H&E) staining and immunofluorescence experiments as well as Western blotting and reverse transcription quantitative (RT q) PCR analyses were performed. Recombinant CTRP13 was used to investigate the role of CTRP13 in chronic renal inflammation and fibrosis. A decreased expression level of CTRP13 was identified in the plasma of patients with renal fibrosis and in UUO-model mice. The renal histopathological and functional analyses revealed that CTRP13 could both reverse UUO mediated renal dysfunction and ameliorate the conditions of tubulointerstitial fibrosis and tubular injury. Additionally, CTRP13 was found to inhibit the expression levels of extracellular matrix proteins and proinflammatory mediators. In terms of the underlying mechanism, the protective effects on inflammation and fibrosis of the kidneys of CTRP13-treated mice undergoing UUO were found to be associated with the inactivation of the TGF β/Smad and NF κB p65 signaling pathways. Taken together, these findings have suggested that CTRP13 fulfills a vital role in the progression of obstructive nephropathy, thereby uncovering brand new insights into possible leads for the therapeutic treatment of chronic kidney disease (CKD).
Insights
C1q/tumor necrosis factor-related protein 13 (CTRP13) combats renal inflammation and fibrosis in obstructive nephropathy by inhibiting key signaling pathways. This discovery offers new therapeutic avenues for chronic kidney disease (CKD).
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Obstructive nephropathy involves renal inflammation and fibrosis, but mechanisms remain unclear.
- C1q/tumor necrosis factor-related protein 13 (CTRP13) role in kidney disease is under investigation.
- Reduced CTRP13 levels are observed in renal fibrosis patients and models.
Purpose of the Study:
- Investigate CTRP13's effects on renal inflammation and fibrosis in obstructive nephropathy.
- Elucidate the underlying molecular mechanisms of CTRP13's action.
- Assess CTRP13 as a potential therapeutic target for chronic kidney disease (CKD).
Main Methods:
- Established a mouse unilateral ureteral obstruction (UUO) model for renal dysfunction.
- Utilized hematoxylin-eosin staining, immunofluorescence, Western blotting, and RT-qPCR.
- Administered recombinant CTRP13 to assess its therapeutic potential.
Main Results:
- CTRP13 expression was decreased in renal fibrosis patients and UUO mice.
- CTRP13 administration reversed UUO-induced renal dysfunction, fibrosis, and tubular injury.
- CTRP13 inhibited extracellular matrix proteins and pro-inflammatory mediators.
- CTRP13's protective effects were linked to inactivating TGF-β/Smad and NF-κB p65 pathways.
Conclusions:
- CTRP13 plays a crucial role in mitigating renal inflammation and fibrosis.
- CTRP13 demonstrates therapeutic potential for obstructive nephropathy and CKD.
- Inactivation of TGF-β/Smad and NF-κB pathways mediates CTRP13's protective effects.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Antihypertensive Drugs: Direct Renin Inhibitors
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors